Reckitt’s baby formula sales to suffer after tornado damages Indiana warehouse

Reckitt’s baby formula sales to suffer after tornado damages Indiana warehouse


Enfimil infant formula, made by Mead Johnson Nutrition Co., sits on display in a supermarket in New York, U.S.

Daniel Acker | Bloomberg News | Getty Images

Sales of Reckitt‘s Mead Johnson baby formula powder are likely to take a short-term hit after a tornado damaged a third-party warehouse in the United States, the British consumer goods company said on Wednesday.

The Mount Vernon warehouse in Indiana, out of action since the tornado struck on July 9, is an important site for the company’s Mead Johnson Nutrition business, containing both raw materials and finished products, Reckitt said.

All employees are safe, the company added, saying it had diverted deliveries to other warehouses in the United States.

Some nutrition product varieties are likely to be affected in the short term, a Reckitt spokesperson said.

The company could not estimate when the warehouse would be up and running again, but said it was working as quickly as possible with local authorities and regulators to minimize the disruption.

“We are partnering with customers and suppliers on expedited recovery efforts to minimize disruption by leveraging our global supply chain and managing inventory at our other U.S. warehouses,” the spokesperson said.

This is not the first time Reckitt has had to rely on its worldwide supply chain in an emergency, which can take time because of the regulatory hurdles the company needs to clear with the U.S. Food & Drug Administration.

In 2022, during a months-long U.S. shortage of baby formula, Reckitt flew 65 tons of baby formula to Chicago from its plant in Singapore. A few months before, it said it was working with the FDA to increase baby formula supply, including expediting the approval of some products made at a facility in Mexico.

Reckitt said on Wednesday it had comprehensive property damage and business interruption insurance, which it expects will largely offset the impact on earnings.

This marks a third setback for the company this year.

In February, an investigation showed some employees had under-reported liabilities in the Middle East, triggering the biggest one-day drop in Reckitt’s shares since December 1999.

A month later, the stock tumbled again after an Illinois jury ordered Reckitt’s Mead Johnson unit to pay $60 million to the mother of a premature baby who died of an intestinal disease after allegedly being fed the company’s Enfamil Premature 24 baby formula products.

Reckitt’s stock, which was down 0.5% on Wednesday morning, has lost about 21% so far this year.



Source

Payrolls rose by 64,000 in November after falling by 105,000 in October, delayed jobs numbers show
World

Payrolls rose by 64,000 in November after falling by 105,000 in October, delayed jobs numbers show

A “Help Wanted” sign hangs in a restaurant window in Medford, Massachusetts, Jan. 25, 2023. Brian Snyder | Reuters Nonfarm payrolls grew slightly more than expected in November but slumped in October while unemployment hit its highest in four years, the Bureau of Labor Statistics reported Tuesday in numbers delayed by the government shutdown. Job […]

Read More
Oil prices tumble to lowest since May, on pace for biggest annual decline in 7 years
World

Oil prices tumble to lowest since May, on pace for biggest annual decline in 7 years

Oil prices held on to most gains from the previous session in early trading on Thursday as investors awaited U.S.-China trade talks later in the day. Anton Petrus | Moment | Getty Images U.S. crude oil on Tuesday hit the lowest level since May, putting prices on pace for the worst performance in seven years […]

Read More
Europe’s best-performing stock is up 1,400% this year. Here’s what’s next
World

Europe’s best-performing stock is up 1,400% this year. Here’s what’s next

Key Points Abivax shares are up more than 1,400% year to date as investors are optimistic about the prospects of its treatment for ulcerative colitis.  “We are certainly excited about the work we are doing, and we’ve been greeted again by the medical community as becoming possibly this next standard of care in ulcerative colitis,” […]

Read More